Increased Expression of the Antiapoptotic Protein MCL1 in Canine Mast Cell Tumors-Reference-Cited by-同舟云学术

Increased Expression of the Antiapoptotic Protein MCL1 in Canine Mast Cell Tumors

Published:2013 Issue:7 Volume:75 Page:971-974
ISSN:0916-7250
Container-title:Journal of Veterinary Medical Science
language:en
Short-container-title:The Journal of Veterinary Medical Science

Author:

AMAGAI Yosuke¹,TANAKA Akane¹²,MATSUDA Akira³,OIDA Kumiko¹,JUNG Kyungsook¹,NISHIKAWA Sho¹,JANG Hyosun¹,ISHIZAKA Saori¹,MATSUDA Hiroshi¹³

Affiliation:

1. Cooperative Major in Advanced Health Science, Graduate School of Bio-Applications and System Engineering, Tokyo University of Agriculture and Technology, Saiwai-cho, Fuchu, Tokyo 183–8509, Japan

2. Laboratory of Comparative Animal Medicine, Division of Animal Life Science, Tokyo University of Agriculture and Technology, Saiwai-cho, Fuchu, Tokyo 183–8509, Japan

3. Laboratory of Veterinary Molecular Pathology and Therapeutics, Division of Animal Life Science, Tokyo University of Agriculture and Technology, Saiwai-cho, Fuchu, Tokyo 183–8509, Japan

Publisher

Japanese Society of Veterinary Science

Subject

General Veterinary

Link

https://www.jstage.jst.go.jp/article/jvms/75/7/75_13-0025/_pdf

Reference25 articles.

1. 1. Aichberger, K. J., Mayerhofer, M., Gleixner, K. V., Krauth, M. T., Gruze, A., Pickl, W. F., Wacheck, V., Selzer, E., Müllauer, L., Agis, H., Sillaber, C. and Valent, P. 2007. Identification of MCL1 as a novel target in neoplastic mast cells in systemic mastocytosis: inhibition of mast cell survival by MCL1 antisense oligonucleotides and synergism with PKC412. Blood 109: 3031–3041.

2. 2. Akgul, C. 2009. Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell. Mol. Life Sci. 66: 1326–1336.

3. 3. Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T. and Saltiel, A. R. 1995. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J. Biol. Chem. 270: 489–494.

4. 4. Amagai, Y., Tanaka, A., Matsuda, A., Oida, K., Jung, K. and Matsuda, H.The phosphoinositide 3-kinase pathway is crucial for the growth of canine mast cell tumors. J. Vet. Med. (in press).

5. 5. Blackwood, L., Murphy, S., Buracco, P., De Vos, J. P., De Fornel-Thibaud, P., Hirschberger, J., Kessler, M., Pastor, J., Ponce, F., Savary-Bataille, K. and Argyle, D. J. 2012. European consensus document on mast cell tumours in dogs and cats. Vet. Comp. Oncol. 10: e1–e29.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetic Changes in Mastocytes and Their Significance in Mast Cell Tumor Prognosis and Treatment;Genes;2024-01-22

2. miR-1 and miR-133b expression in canine osteosarcoma;Research in Veterinary Science;2018-04

3. LncRNA NEAT1 promotes dexamethasone resistance in multiple myeloma by targeting miR-193a/MCL1 pathway;Journal of Biochemical and Molecular Toxicology;2017-12-04

4. Mechanisms of tumour resistance against chemotherapeutic agents in veterinary oncology;The Veterinary Journal;2016-01